Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)
Clinical trial NCT03065621 · COMPLETED
Trial details
- NCT number
- NCT03065621
- Sponsor
- Jules Bordet Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2019-03-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.